Ki Health Partners, LLC dba New England Institute for Clinical Research
Stamford, Connecticut, United States
Research institute in Stamford, Connecticut
30 Buxton Farm Rd # 230, Stamford, CT 06905
About Ki Health Partners, LLC dba New England Institute for Clinical Research
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Ki Health Partners, LLC dba New England Institute for Clinical Research
During the past decade, Ki Health Partners, LLC dba New England Institute for Clinical Research conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 7 clinical trials were completed, i.e. on
average, 38.9% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 7 clinical trials were completed. i.e. 77.8%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
S9811 Hydroxyurea in Treating Patients With Unresectable Benign Meningioma
1998-11-01
2011-07-01
Completed
29
High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
1998-12-01
2025-10-01
Active, not recruiting
1,150
Methotrexate With or Without Cyclophosphamide in Treating Patients With Lymphocytic Leukemia
1999-07-16
2012-03-01
Terminated
59
Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
2000-10-01
2019-11-01
Completed
1,772
S0001 RT and Carmustine With or Without O6BG in Patients With New Glioblastoma Multiforme or Gliosarcoma
2001-09-01
2012-11-01
Completed
183
Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
2002-05-01
2014-06-01
Completed
3,871
Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With AML Leukemia
2002-12-01
2019-12-01
Completed
657
Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
2002-12-01
2016-12-01
Completed
546
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Ki Health Partners, LLC dba New England Institute for Clinical Research" #1 sponsor was "Pfizer" with 8 trials, followed by "Biohaven Pharmaceuticals, Inc." with 3 trials
sponsored, "H. Lundbeck A/S" with 2 trials sponsored, "Revance Therapeutics, Inc." with 2 trials sponsored and "Cognition Therapeutics"
with 2 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Ki Health Partners, LLC dba New England Institute for Clinical Research"
#1 collaborator was "Alder Biopharmaceuticals, Inc." with 1 trials as a collaborator, "Alzheimer's Disease Cooperative Study (ADCS)" with 1 trials as a collaborator and "Syneos Health" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Ki Health Partners, LLC dba New England Institute for Clinical Research
According to Clinical.Site data, the most researched conditions in "Ki Health Partners, LLC dba New England Institute for Clinical Research" are
"Migraine" (7 trials), "Acute Migraine" (1 trials), "Acute Treatment of Migraine" (1 trials), "Alzheimer Disease" (1 trials) and "Alzheimer's Disease" (1 trials). Many other conditions were trialed in "Ki Health Partners, LLC dba New England Institute for Clinical Research" in a lesser frequency.
Clinical Trials Intervention Types at Ki Health Partners, LLC dba New England Institute for Clinical Research
Most popular intervention types in "Ki Health Partners, LLC dba New England Institute for Clinical Research" are "Drug" (16 trials), "Biological" (2 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (12 trials), "Rimegepant" (4 trials), "Eptinezumab" (2 trials), "Zavegepant" (2 trials) and "BHV-3500 (zavegepant)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Ki Health Partners, LLC dba New England Institute for Clinical Research
The vast majority of trials in "Ki Health Partners, LLC dba New England Institute for Clinical Research" are
18 trials for "All" genders.
Clinical Trials Status at Ki Health Partners, LLC dba New England Institute for Clinical Research
Currently, there are NaN active trials in "Ki Health Partners, LLC dba New England Institute for Clinical Research".
undefined are not yet recruiting,
8 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 10 completed trials in Ki Health Partners, LLC dba New England Institute for Clinical Research,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Ki Health Partners, LLC dba New England Institute for Clinical Research, 0 "Phase 1"
clinical trials were conducted, 8 "Phase 2" clinical
trials and 13 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".